ReposiTrak 配当と自社株買い
配当金 基準チェック /26
ReposiTrakは配当を支払う会社で、現在の利回りは0.86%ですが、利益によって十分にカバーされています。次の支払い日は 14th August, 2026で、権利落ち日は30th June, 2026 。
主要情報
0.9%
配当利回り
1.1%
バイバック利回り
| 総株主利回り | 1.9% |
| 将来の配当利回り | n/a |
| 配当成長 | 22.7% |
| 次回配当支払日 | 14 Aug 26 |
| 配当落ち日 | 30 Jun 26 |
| 一株当たり配当金 | n/a |
| 配当性向 | 20% |
最近の配当と自社株買いの更新
Recent updates
Seeking Alpha • Jun 20
ReposiTrak: Walmart And Kroger May Prove The Bears Wrong
Summary ReposiTrak earns a buy rating, targeting $10.2/share by FY 2027, implying 11% upside after a sharp recent pullback. TRAK’s fundamentals remain solid, with profitability and operating leverage improving despite flat Q3 revenue due to FSMA compliance deadline timing shifts. Demand for TRAK’s traceability solutions appears robust, supported by retailer adoption and industry trends beyond regulatory requirements. Risks include slower-than-expected traceability adoption, but TRAK’s scalable SaaS model and regulatory tailwinds underpin an attractive risk-reward profile. Read the full article on Seeking Alpha
ナラティブの更新 • Jun 03
TRAK: Expanding Traceability And Compliance Adoption Will Support Future Upside Potential
Analysts have adjusted their price target on ReposiTrak to $16.00. The update reflects refreshed assumptions around revenue growth, profit margins, the discount rate and a slightly lower future P/E multiple.ナラティブの更新 • May 05
TRAK: Expanding Food Traceability Adoption And Compliance Wins Will Drive Upside
Analysts have kept their ReposiTrak price target effectively unchanged at approximately $16.00, reflecting only very small tweaks in inputs such as discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their overall view of the stock. What's in the News A wholesale grocery cooperative in the Southern United States became the first wholesaler to reach full supplier to store traceability using ReposiTrak’s Touchless Traceability solution, achieving FSMA 204 compliance without case-level scanning or changes to distribution center workflows (Key Developments).ナラティブの更新 • Apr 19
TRAK: Expanding Traceability Network Adoption Will Support Future Upside
Analysts held ReposiTrak's fair value estimate at $16.00 per share while making only very small tweaks to assumptions such as the discount rate and future P/E, reflecting largely unchanged views on the stock's risk and earnings profile. What's in the News ReposiTrak reported that eighteen fresh fruit and vegetable companies have joined the queue for the ReposiTrak Traceability Network to prepare for FDA Key Data Element sharing across their supply chains, covering a wide range of growers and distributors across the United States (Key Developments).ナラティブの更新 • Apr 04
TRAK: Expanding Traceability Adoption And Share Repurchases Will Support Future Upside
Analysts have maintained their $16.00 price target on ReposiTrak, linking this steady view to only slight adjustments in discount rate and future P/E assumptions rather than any change in projected growth or profitability. What's in the News ReposiTrak and SPAR Group, Inc.ナラティブの更新 • Mar 21
TRAK: Expanding Traceability Adoption And Share Repurchases Will Support Future Upside
Analysts have reaffirmed a $16.00 price target for ReposiTrak, citing only minimal tweaks to underlying assumptions such as discount rate, revenue growth, profit margin and future P/E, which together leave their overall valuation view effectively unchanged. What's in the News A grocery retailer using ReposiTrak Touchless Traceability is reported as the first to achieve end to end traceability under FDA FSMA Section 204, with hundreds of thousands of Key Data Element records generated across shipments, and several more corporate customers nearing similar go live milestones (Key Developments).ナラティブの更新 • Mar 06
TRAK: Expanding Traceability Network And Share Buybacks Will Support Future Upside
Analysts have modestly reduced their price target on ReposiTrak to reflect a slightly lower future P/E assumption of 36.44x, while keeping key fair value and growth inputs broadly unchanged. What's in the News A grocery retailer using ReposiTrak Touchless Traceability has achieved end to end FSMA 204 traceability, generating hundreds of thousands of FDA Key Data Element records without case level scanning, with three more corporate customers close to similar go live points (Key Developments).ナラティブの更新 • Feb 19
TRAK: Traceability Network Adoption Will Support Higher Future Profitability
Analysts have reduced their price target on ReposiTrak from $29 to $16, citing updated assumptions in their models for slower revenue growth, a lower future P/E multiple, and a higher profit margin profile. What's in the News ReposiTrak reported completing a share repurchase program announced on May 9, 2019, buying back a total of 2,220,026 shares, or 11.63% of the company, for US$14.46 million, including 79,927 shares, or 0.44%, repurchased between October 1, 2025 and December 31, 2025 for US$1.1 million (Key Developments).分析記事 • Oct 01
Investors Will Want ReposiTrak's (NYSE:TRAK) Growth In ROCE To Persist
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...分析記事 • Aug 02
Subdued Growth No Barrier To ReposiTrak, Inc.'s (NYSE:TRAK) Price
ReposiTrak, Inc.'s ( NYSE:TRAK ) price-to-earnings (or "P/E") ratio of 46.4x might make it look like a strong sell...分析記事 • May 27
ReposiTrak's (NYSE:TRAK) Performance Is Even Better Than Its Earnings Suggest
ReposiTrak, Inc. ( NYSE:TRAK ) just reported healthy earnings but the stock price didn't move much. Investors are...分析記事 • Apr 12
Earnings Not Telling The Story For ReposiTrak, Inc. (NYSE:TRAK)
With a price-to-earnings (or "P/E") ratio of 62.3x ReposiTrak, Inc. ( NYSE:TRAK ) may be sending very bearish signals...分析記事 • Nov 09
ReposiTrak, Inc. (NYSE:TRAK) Not Lagging Market On Growth Or Pricing
With a price-to-earnings (or "P/E") ratio of 71.3x ReposiTrak, Inc. ( NYSE:TRAK ) may be sending very bearish signals...
新しいナラティブ • Oct 07
Critical Focus On Traceability Solutions Powers Revenue Growth And Profitability Surge
Emphasis on enhancing traceability solutions and strategic revenue focus predicts significant growth, with aims to improve net margins and year-over-year growth.Seeking Alpha • Oct 06
Track And Trace, But Don't Race: Why ReposiTrak Might Be Overvalued
Summary ReposiTrak shows solid growth potential with traceability services and recurring revenue but is currently overvalued with a high P/E ratio of 62.09x. Despite strong financials and profitability, rising operational expenses and heavy FDA dependency pose significant risks. Expansion into adjacent markets and AI-driven operational efficiencies are promising, but traceability revenue remains a small portion of the business. Given the speculative nature and high valuation, I recommend holding off on investing in ReposiTrak at this price. Read the full article on Seeking Alpha分析記事 • Jul 24
ReposiTrak, Inc.'s (NYSE:TRAK) P/E Is Still On The Mark Following 28% Share Price Bounce
ReposiTrak, Inc. ( NYSE:TRAK ) shareholders have had their patience rewarded with a 28% share price jump in the last...分析記事 • Mar 23
ReposiTrak (NYSE:TRAK) Has More To Do To Multiply In Value Going Forward
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...分析記事 • Feb 28
Why Investors Shouldn't Be Surprised By ReposiTrak, Inc.'s (NYSE:TRAK) 28% Share Price Surge
Despite an already strong run, ReposiTrak, Inc. ( NYSE:TRAK ) shares have been powering on, with a gain of 28% in the...配当金の支払いについて
決済の安定と成長
配当データの取得
安定した配当: 配当金の支払いは安定していますが、 TRAKが配当金を支払っている期間は 10 年未満です。
増加する配当: TRAKの配当金は増加していますが、同社は4年間しか配当金を支払っていません。
配当利回り対市場
| ReposiTrak 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (TRAK) | 0.9% |
| 市場下位25% (US) | 1.4% |
| 市場トップ25% (US) | 4.3% |
| 業界平均 (Software) | 1.0% |
| アナリスト予想 (TRAK) (最長3年) | n/a |
注目すべき配当: TRAKの配当金 ( 0.86% ) はUS市場の配当金支払者の下位 25% ( 1.39% ) と比べると目立ったものではありません。
高配当: TRAKの配当金 ( 0.86% ) はUS市場の配当金支払者の上位 25% ( 4.29% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: TRAKは低い 配当性向 ( 20.2% ) であるため、配当金の支払いは利益によって十分にカバーされます。
株主配当金
キャッシュフローカバレッジ: TRAKは低い 現金配当性向 ( 19.4% ) であるため、配当金の支払いはキャッシュフローによって十分にカバーされています。
高配当企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/06/21 11:43 |
| 終値 | 2026/06/18 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/06/30 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
ReposiTrak, Inc. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4
| アナリスト | 機関 |
|---|---|
| Thomas Forte | D.A. Davidson & Co. |
| Ananda Baruah | Loop Capital Markets |
| Thomas Forte | Maxim Group |